STOCK TITAN

Skye Bioscience, Inc. (SKYE) Net Income by Year

SKYE

Skye Bioscience, Inc. reported a net loss of $55.9M in fiscal year 2025. This represents a decrease of 110.5% from the prior fiscal year. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Skye Bioscience, Inc. has filed alongside them.

FY2025 annual
Net Income -$55.9M
YoY -110.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SKYE Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Net Income-$55.9M-110.5%-$26.6M+29.4%-$37.6M-93.2%-$19.5M-128.6%-$8.5M-29.9%-$6.6M-723.7%$1.1MN/AN/AN/A-$4.8MN/A-$120K-2770.3%$5K

SKYE Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$10.8M+38.8%-$12.5M-12.7%N/A-$12.8M-227.2%-$17.6M-123.0%-$11.1M-121.2%N/A-$3.9M+84.4%-$7.9M-154.0%-$5.0M+2.9%N/A-$24.9M-697.7%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Skye Bioscience, Inc. financials

Frequently Asked Questions

What was Skye Bioscience, Inc.'s net income in fiscal year 2025?

Skye Bioscience, Inc. reported a net loss of $55.9M in fiscal year 2025.

How fast is Skye Bioscience, Inc.'s net income growing?

Skye Bioscience, Inc. (SKYE) net income fell by 110.5% year over year, from -$26.6M to -$55.9M in fiscal year 2025.

How has Skye Bioscience, Inc.'s net income changed over the years?

Across the 14 fiscal years this page covers, Skye Bioscience, Inc. (SKYE) net income went from $5K in fiscal year 2012 to -$55.9M in fiscal year 2025.

Skye Bioscience, Inc. (SKYE) reported -$10.8M in net income in Q2 2026. This represents an increase of 38.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Skye Bioscience, Inc. (SKYE) reported on that line in every period on record.